Companies: 10,795·Total market cap: $144.5T
Evolent Health, Inc.

Evolent Health, Inc.

EVHNYSEHealthcare● Active
$4.63
+$0.41(+9.60%)
Market Cap$520224935
P/E Ratio
52W High$12.065
52W Low$2.095

Evolent Health, Inc. (EVH) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

evh · stock forecast · 29 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 29 Wall Street analysts in the past 3 months

SellBuy

Buy

29 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
23
Hold
6
Sell
0
Strong Sell
0
Total: 29 · Buy rate: 79.3%

12-Month Price Target

High

$10.00

Consensus

$6.38

+38.8% upside

Low

$3.50

Median: $6 · Last Close: $4.59

The Evolent Health, Inc. (EVH) analyst consensus is Buy, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month EVH price target is $6.38, representing +38.8% upside from the current price of $4.59.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $6 (38.8%)

Consensus Target

$6.38

38.8% upside

High Target

$10

117.6%

Low Target

$3.5

-23.8%

Current Price

$4.59

as of today

Based on analyst price targets, the EVH stock price prediction for the next 12 months ranges from $3.5 to $10. The consensus EVH price forecast of $6.38 implies 38.8% upside from the current price of $4.59.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$4.732.86%

1-day model range: $4.68–$4.77. Peak: $4.77 (+2.86%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$2-50.0%
2028$2-63.8%
2029$1-69.2%
2030$1-71.8%
2031-73.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

79%7%14%
11Buy
1Neutral
2Sell
RSI (14)64.6Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · EVH · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$4.19BUY
MA 10$4.05BUY
MA 20$4.01BUY
MA 50$3.42BUY
MA 100$3.25BUY
MA 200$4.85SELL
Current $EVH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.28BUY
EMA 10$4.14BUY
EMA 20$3.99BUY
EMA 50$3.67BUY
EMA 100$3.78BUY
EMA 200$5.13SELL
Current $EVH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citigroup2026-05-15
Maintains
BuyBuy
Canaccord Genuity2026-05-12
Maintains
BuyBuy
Needham2026-05-07
Maintains
BuyBuy
Oppenheimer2026-03-02
Maintains
OutperformOutperform
UBS2026-02-26
Maintains
BuyBuy
Truist Securities2026-02-26
Maintains
BuyBuy
Citigroup2026-02-26
Maintains
BuyBuy
BTIG2026-02-25
Maintains
BuyBuy
Needham2026-02-25
Maintains
BuyBuy
RBC Capital2026-02-25
Maintains
Sector PerformSector Perform

Wall Street analysts have recently issued updated ratings on Evolent Health, Inc. (EVH) stock. Of the recent 144 rating actions, 2 were upgrades and 6 were downgrades. 29 analysts currently cover EVH.

Analyst Recommendation Trends

Buy ratings33
Hold ratings101
Sell ratings00

EVH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2.5B

↓ 25.3% YoY

Revenue Next Year

$2.9B

↑ 17.7% YoY

EPS This Year

$0.17

EPS Next Year

$0.38

↑ 121.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EVH EPS of $0.17 for the current fiscal year, based on estimates from 7 analysts. The EVH revenue forecast is $2.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The EVH stock forecast is supported by two independent data sources: analyst consensus ratings from 29 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EVH price target is $6.38 (+38.8% upside), with an analyst consensus of Buy.

The EVH short-term stock prediction for tomorrow is $4.73 (+2.86%). The EVH stock price prediction for 2027 estimates an average of $2. The EVH stock prediction for 2030 projects a range of $1–$1.

Evolent Health, Inc. trades on NYSE under the ticker EVH. The EVH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 79% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

EVH forecast · 8 questions

According to 29 Wall Street analysts, the average 12-month EVH price target is $6.38, with a high forecast of $10.00 and a low of $3.50. The median price target is shown in the chart above when available. This implies +38.8% potential upside from the current price of $4.59.

EVH price targetWhat is EVH price targetEVH analyst price targetEVH 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.